The effect of L-carnitine on cardiac hemodynamics was evaluated in normal closed chest dogs. Extracorporeal circulation was produced to measure coronary blood flow in closed chest dogs. Coronay venous blood was introduced to the extracorporeal circuit through a polyethylene catheter wedged into the coronay sinus under fluoroscopic control and was returned to the animal through the left jugular vein. L-carnitine was infused intravenously at a constant rate of 80mg/Kg/min for 8min. Hemodynamic responses appeared within 1 to 3min of carnitine infusion and peak effects were observed nearly after 5min. Peak effects on cardiac hemodynamics after 5 to 8min of carnitine infusion were as follows. Heart rate decreased by 17% from control (p<0.05). Aortic and left ventricular pressure increased by 20% (p<0.05 and p<0.01 respectively) and peak positive left ventricular dp/dt increased by 35% (p<0.01), the mean rate pressure product as the index of myocardial oxygen consumption remained unchanged. Coronary blood flow increased by 60% (p<0.001) and coronary vascular resistance decreased by 25% (p<0.01). As the infusion of carnitine was discontinued, the effects promptly disappeared. These data suggest that L-carnitine has direct vasodilating and positive inotropic effects on cardiovascular system.
SUMMARY
The effect of L-carnitine on cardiac hemodynamics was evaluated in normal closed chest dogs. Extracorporeal circulation was produced to measure coronary blood flow in closed chest dogs. Coronay venous blood was introduced to the extracorporeal circuit through a polyethylene catheter wedged into the coronay sinus under fluoroscopic control and was returned to the animal through the left jugular vein. L-carnitine was infused intravenously at a constant rate of 80mg/Kg/min for 8min. Hemodynamic responses appeared within 1 to 3min of carnitine infusion and peak effects were observed nearly after 5min. Peak effects on cardiac hemodynamics after 5 to 8min of carnitine infusion were as follows. Heart rate decreased by 17% from control (p<0.05). Aortic and left ventricular pressure increased by 20% (p<0.05 and p<0.01 respectively) and peak positive left ventricular dp/dt increased by 35% (p<0.01), the mean rate pressure product as the index of myocardial oxygen consumption remained unchanged. Coronary blood flow increased by 60% (p<0.001) and coronary vascular resistance decreased by 25% (p<0.01). As the infusion of carnitine was discontinued, the effects promptly disappeared. These data suggest that L-carnitine has direct vasodilating and positive inotropic effects on cardiovascular system. Extracorporeal circulation was produced to measure coronary blood flow in closed chest dogs. Coronary venous blood was introduced to the extracorporeal circuit through a polyethylene catheter wedged into the coronary sinus and was returned to the animal through the left jugular vein. Electrocardiogram (ECG), heart rate (HR), pulsatile and mean coronary blood flow (CBF and mCBF), mean aortic pressure (mAoP), left ventricular pressure (LVP), and the first derivative of left ventricular pressure (LV dp/dt) were recorded simultaneously on a multichannel recorder as shown on the right. ; dp/dt=left ventricular dp/dt; CBF=coronary blood flow; CVR=coronary vascular resistance. Fig.3 . Hemodynamic data from a representative animal during infusion of L-carnitine at a rate of 80mg/Kg/min.
Additional
Abbreviations as in Fig.1 . pened to be present in the control period disappeared during carnitine infusion and reappeared after the discontinuation of the infusion.
DISCUSSION
As a cause of toxic effects of high plasma free fatty acids, accumulation of long chain acyl CoA has been proposed.11) Since high levels of long chain acyl CoA inhibits adenine nucleotide translocase activity21)-23) that is the regulator of the egression of ATP across the inner mitochondrial membrane, ATP production in ischemic myocardium is limited both by the reduced supply of oxygen and by the accumulated long chain acyl CoA. L-carnitine 100 mg/Kg that was administered intravenously prior to coronary artery ligation prevented the accumulation of long chain acyl CoA and ATP depletion in ischemic myocardium and serious ventricular arrhythmias in early phases of myocardial ischemia.15)
Hemodynamic effects of L-carnitine were evaluated in this study at a dose of 80mg/Kg/min, because only minimal hemodynamic changes were observed at smaller doses (20 and 40mg/Kg/min) although metabolic improvement had been observed in ischemic myocardium.15)
The most pronounced response was found in the increase in coronary blood flow. Since it was accompanied by the decrease in coronary vascular Jpn. Heart J. M arch 1981
resistance and mean rate pressure product as the index of myocardial oxygen consumption remained unchanged, the increase in coronary blood flow is supposed to be due to the direct vasodilating effect on coronary vascular bed . The increase in left ventricular dp/dt despite the drop in heart rate indicates that L-carnitine has a positive inotropic effect, and the reduced heart rate may result from the reflex to the increase in left ventricular pressure. The onset of hemodynamic responses to L-carnitine was very rapid and the effects promptly disappeared as the infusion was discontinued. And these effects were not observed at lower doses although metabolic improvement had been demonstrated.
Therefore the hemodynamic changes observed in this study appear to result not from the improvement of fatty acid metabolism that is the most important property of carnitine, but from direct pharmacological effects on cardiovascular system. Although the mechanism of the effects is not well understood, it has been demonstrated that the vasodilating effect was not blocked by propranolol or by atropine and it was still present in the reserpinized catecholamine depleted animal.19)
On the study using DL-carnitine, frequent premature ventricular contractions have been reported to occur at doses higher than 60mg/Kg/min, whereas no significant dysrhythmias developed at the moderate or lower doses.19) In this study using L-carnitine, on the other hand, no arrhythmias were observed during the infusion of L-carnitine at a rate of 80mg/Kg/min and premature ventricular contractions that happened to be present before carnitine infusion disappeared during the infusion.
The administration of exogenous carnitine has been demonstrated to prevent ATP depletion in ischemic myocardium and serious arrhythmias in early phases of myocardial infarction.14),15) And these effects are supposed to result from improvement of impaired fatty acid metabolism. Catecholamines most widely used today for cardiogenic shock not only to increase myocardial oxygen consumption but also to stimulate lipolysis, resulting in high plasma free fatty acids. And those metabolic changes are supposed to exaggerate ischemic damage of myocardium.
Taking these observations into considerations, the results in this study suggest that L-carnitine may be beneficial for the treatment of cardiogenic shock not only from metabolic but also hemodynamic point of view. 
